Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6E1A

Menin bound to M-89

6E1A の概要
エントリーDOI10.2210/pdb6e1a/pdb
分子名称Menin, (1S,2R)-2-[(4S)-2-methyl-4-{1-[(1-{4-[(pyridin-4-yl)sulfonyl]phenyl}azetidin-3-yl)methyl]piperidin-4-yl}-1,2,3,4-tetrahydroisoquinolin-4-yl]cyclopentyl methylcarbamate, praseodymium triacetate, ... (4 entities in total)
機能のキーワードinhibitor, protein binding, transcription
由来する生物種Homo sapiens (Human)
タンパク質・核酸の鎖数1
化学式量合計63309.30
構造登録者
Stuckey, J.A. (登録日: 2018-07-09, 公開日: 2019-07-10, 最終更新日: 2023-10-11)
主引用文献Aguilar, A.,Zheng, K.,Xu, T.,Xu, S.,Huang, L.,Fernandez-Salas, E.,Liu, L.,Bernard, D.,Harvey, K.P.,Foster, C.,McEachern, D.,Stuckey, J.,Chinnaswamy, K.,Delproposto, J.,Kampf, J.W.,Wang, S.
Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein-Protein Interaction.
J.Med.Chem., 62:6015-6034, 2019
Cited by
PubMed Abstract: Inhibition of the menin-mixed lineage leukemia (MLL) protein-protein interaction is a promising new therapeutic strategy for the treatment of acute leukemia carrying MLL fusion (MLL leukemia). We describe herein our structure-based design, synthesis, and evaluation of a new class of small-molecule inhibitors of the menin-MLL interaction (hereafter called menin inhibitors). Our efforts have resulted in the discovery of highly potent menin inhibitors, as exemplified by compound (M-89). M-89 binds to menin with a value of 1.4 nM and effectively engages cellular menin protein at low nanomolar concentrations. M-89 inhibits cell growth in the MV4;11 and MOLM-13 leukemia cell lines carrying MLL fusion with IC values of 25 and 55 nM, respectively, and demonstrates >100-fold selectivity over the HL-60 leukemia cell line lacking MLL fusion. The determination of a co-crystal structure of M-89 in a complex with menin provides the structural basis for their high-affinity interaction. Further optimization of M-89 may lead to a new class of therapy for the treatment of MLL leukemia.
PubMed: 31244110
DOI: 10.1021/acs.jmedchem.9b00021
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.1 Å)
構造検証レポート
Validation report summary of 6e1a
検証レポート(詳細版)ダウンロードをダウンロード

232829

件を2025-03-12に公開中

PDB statisticsPDBj update infoContact PDBjnumon